These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1156036)

  • 21. Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.
    Heikkila RE; Cabbat FS; Mytilineou C
    Eur J Pharmacol; 1977 Oct; 45(4):329-33. PubMed ID: 923643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of monoamine oxidase and catechol O-methyltransferase inhibitors on the accumulation and metabolism of [l-3H] norepinephrine by the adventitia and media of rabbit aorta.
    Levin JA; Wilson SE
    J Pharmacol Exp Ther; 1977 Dec; 203(3):598-609. PubMed ID: 925961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

  • 24. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
    Rastoge RB; Singhal RL
    J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of spiperone on feeding parameters in the rat and interactions with (+)-amphetamine, mazindol or (+/-)-fenfluramine [proceedings].
    Cooper SJ; Sweeney KF
    Br J Pharmacol; 1979 May; 66(1):147P-148P. PubMed ID: 454939
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of three anorectic drugs on central catecholamine levels and synthesis in the Zucker rat.
    Orosco M; Bremond J; Jacquot C; Cohen Y
    Gen Pharmacol; 1983; 14(3):337-42. PubMed ID: 6873624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on maxindol as an amine uptake inhibitor.
    Fuller RW; Snoddy HD; Wong DT; Bymaster FP
    Commun Psychopharmacol; 1978; 2(3):223-30. PubMed ID: 699537
    [No Abstract]   [Full Text] [Related]  

  • 28. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL; Zarrindast MR
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemistry and pharmacology of mazindol.
    Gogerty JH; Trafold JH
    Triangle; 1976; 15(1):25-36. PubMed ID: 960214
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of thyroid hormone on norepinephrine metabolism in rat brain during maturation.
    Schwark WS; Keesey RR
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):673-83. PubMed ID: 1265345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mazindol enhances glucose uptake by rat skeletal muscle.
    Nagai K; Nagai N; Isojima Y; Itoh S; Okumura N; Nakagawa H
    Eur J Pharmacol; 1994 Jul; 260(1):29-37. PubMed ID: 7957623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.
    Westwood NN; Bryan-Lluka LJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):815-21. PubMed ID: 8246156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of mazindol on free fatty acid metabolism in the brain of rats].
    Mizobuchi M; Matsuoka N; Saito Y; Yoshida S; Kumagai A
    Nihon Yakurigaku Zasshi; 1984 Jan; 83(1):33-7. PubMed ID: 6714850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol and acetaldehyde effects on metabolism and binding of biogenic amines.
    Lahti RA; Majchrowicz E
    Q J Stud Alcohol; 1974 Mar; 35(1):1-14. PubMed ID: 4151232
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol.
    Leibowitz SF; Rossakis C
    Eur J Pharmacol; 1978 Dec; 53(1):69-81. PubMed ID: 738361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of monoamine oxidase inhibitors on metabolism and in vivo release of H 3 -norepinephrine from the hypothalamus.
    Strada SJ; Sulser F
    Eur J Pharmacol; 1972 May; 18(3):303-8. PubMed ID: 4556296
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
    Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.